Core Insights - Ocumetics Technology Corp. has successfully completed its second surgical day in Mexico City as part of its clinical study for the Ocumetics Accommodating Intraocular Lens [1] - All procedures were completed safely, reinforcing confidence in the safety profile of the Ocumetics Lens and the surgical protocol [2] - The company is excited about the momentum in its clinical program, with Group 1 patient surgeries now completed [3] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions aimed at enhancing patients' quality of life [4] - The company is in the preclinical study phase of a transformative technology for the ophthalmic industry, developing an intraocular lens that may eliminate the need for corrective lenses [5] Clinical Study Design - The clinical protocol is designed to evaluate three patient groups with specific primary and secondary endpoints [4] - Key areas of evaluation include safety, distance vision correction, product handling and surgical delivery, and near reading ability [6]